PKU HealthCare Corp Ltd Market Cap ($463.09 Million)
Market Cap & Net Worth: PKU HealthCare Corp Ltd (000788)
PKU HealthCare Corp Ltd market cap. PKU HealthCare Corp Ltd (SHE:000788) has a market capitalization of $463.09 Million (CN¥3.16 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #12350 globally and #3561 in its home market, demonstrating a -4.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PKU HealthCare Corp Ltd's stock price CN¥5.31 by its total outstanding shares 595987425 (595.99 Million). Also see 000788 cash generation efficiency for how efficiently the company converts equity into cash flow.
PKU HealthCare Corp Ltd Market Cap History (2015–2026)
PKU HealthCare Corp Ltd market cap history from 2015 to 2026. Data shows change from $1.29 Billion to $463.09 Million (-6.52% CAGR). Check PKU HealthCare Corp Ltd stock price for real-time trading data and today's change.
PKU HealthCare Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PKU HealthCare Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 000788 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.36x
PKU HealthCare Corp Ltd's market cap is 0.36 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.43x
PKU HealthCare Corp Ltd's market cap is 6.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.21 Billion | $2.07 Billion | $12.56 Million | 0.59x | 96.65x |
| 2017 | $744.02 Million | $2.15 Billion | $34.26 Million | 0.35x | 21.72x |
| 2018 | $446.81 Million | $2.32 Billion | $45.18 Million | 0.19x | 9.89x |
| 2019 | $571.74 Million | $2.51 Billion | $50.19 Million | 0.23x | 11.39x |
| 2020 | $527.11 Million | $1.98 Billion | $39.18 Million | 0.27x | 13.45x |
| 2021 | $588.06 Million | $2.24 Billion | $43.14 Million | 0.26x | 13.63x |
| 2022 | $640.56 Million | $2.08 Billion | $55.61 Million | 0.31x | 11.52x |
| 2023 | $577.72 Million | $2.19 Billion | $44.36 Million | 0.26x | 13.02x |
| 2024 | $523.27 Million | $2.06 Billion | $137.99 Million | 0.25x | 3.79x |
| 2025 | $532.86 Million | $1.48 Billion | $82.88 Million | 0.36x | 6.43x |
Competitor Companies of 000788 by Market Capitalization
Companies near PKU HealthCare Corp Ltd in the global market cap rankings as of November 6, 2026. Also see 000788 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to PKU HealthCare Corp Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of PKU HealthCare Corp Ltd (2015–2026)
Market capitalization of PKU HealthCare Corp Ltd from 2015 to today. Between 2015 and today, PKU HealthCare Corp Ltd's market cap moved from $1.29 Billion to $ 463.09 Million, with a yearly change of -6.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥463.09 Million | -13.09% |
| 2025 | CN¥532.86 Million | +1.83% |
| 2024 | CN¥523.27 Million | -9.42% |
| 2023 | CN¥577.72 Million | -9.81% |
| 2022 | CN¥640.56 Million | +8.93% |
| 2021 | CN¥588.06 Million | +11.56% |
| 2020 | CN¥527.11 Million | -7.81% |
| 2019 | CN¥571.74 Million | +27.96% |
| 2018 | CN¥446.81 Million | -39.95% |
| 2017 | CN¥744.02 Million | -38.71% |
| 2016 | CN¥1.21 Billion | -5.71% |
| 2015 | CN¥1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of PKU HealthCare Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $463.09 Million USD |
| MoneyControl | $463.09 Million USD |
| MarketWatch | $463.09 Million USD |
| marketcap.company | $463.09 Million USD |
| Reuters | $463.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PKU HealthCare Corp Ltd
PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment se… Read more